Skip to main content

Caspofungin Dosage

Medically reviewed by Drugs.com. Last updated on Aug 5, 2024.

Applies to the following strengths: 50 mg; 70 mg

Usual Adult Dose for Febrile Neutropenia

Loading dose: 70 mg IV on Day 1
Maintenance dose: 50 mg IV once a day thereafter


Comments:

Use: As empirical therapy for presumed fungal infections in febrile, neutropenic patients

Usual Adult Dose for Candidemia

Loading dose: 70 mg IV on Day 1
Maintenance dose: 50 mg IV once a day thereafter

Comments:


Uses: For the treatment of candidemia and the following Candida infections: intraabdominal abscesses, peritonitis, and pleural space infections

Usual Adult Dose for Esophageal Candidiasis

50 mg IV once a day
Duration of therapy: 7 to 14 days after symptom resolution

Comments:


Use: For the treatment of esophageal candidiasis

Usual Adult Dose for Aspergillosis - Invasive

Loading dose: 70 mg IV on Day 1
Maintenance dose: 50 mg IV once a day thereafter

Comments:


Use: For the treatment of invasive aspergillosis in patients refractory to/intolerant of other therapies

Usual Pediatric Dose for Febrile Neutropenia

3 months or older:

Maximum dose (loading and maintenance): 70 mg/dose

Comments:

Use: As empirical therapy for presumed fungal infections in febrile, neutropenic patients

Usual Pediatric Dose for Candidemia

3 months or older:

Maximum dose (loading and maintenance): 70 mg/dose

Comments:

Uses: For the treatment of candidemia and the following Candida infections: intraabdominal abscesses, peritonitis, and pleural space infections

Usual Pediatric Dose for Esophageal Candidiasis

3 months or older:

Maximum dose (loading and maintenance): 70 mg/dose
Duration of therapy: 7 to 14 days after symptom resolution

Comments:

Use: For the treatment of esophageal candidiasis

Usual Pediatric Dose for Aspergillosis - Invasive

3 months or older:

Maximum dose (loading and maintenance): 70 mg/dose

Comments:

Use: For the treatment of invasive aspergillosis in patients refractory to/intolerant of other therapies

Renal Dose Adjustments

Renal dysfunction: No adjustment recommended.

Liver Dose Adjustments

Adult patients:


Pediatric patients:

Dose Adjustments

Adult patients:


Pediatric patients:

Precautions

CONTRAINDICATIONS:
Known hypersensitivity (e.g., anaphylaxis) to the active component or any of the ingredients

Safety and efficacy have not been established in patients younger than 3 months.

Consult WARNINGS section for additional precautions.

Dialysis

This drug is not dialyzable; supplementary dosing is not required after hemodialysis.

Other Comments

Administration advice:


Storage requirements:

Reconstitution/preparation techniques:

IV compatibility:

Monitoring:

Patient advice:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.